E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.
about
Hijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated Neoplastic PhenotypesEpithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transitionAnoikis resistance: an essential prerequisite for tumor metastasisFour amino acids within a tandem QxVx repeat in a predicted extended α-helix of the Smad-binding domain of Sip1 are necessary for binding to activated Smad proteinsMultigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.P130cas is required for TGF-β1-mediated epithelial-mesenchymal transition in lung cancerUpregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinomaPrognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarrayMechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinomaFoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis.Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinomaActivation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasationCapsaicin treatment attenuates cholangiocarcinoma carcinogenesisChanges in protein expression in two cholangiocarcinoma cell lines undergoing formation of multicellular tumor spheroids in vitroDDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathwayMitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with β-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells.Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion.Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma.Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Antimetastatic effect of halichondramide, a trisoxazole macrolide from the marine sponge Chondrosia corticata, on human prostate cancer cells via modulation of epithelial-to-mesenchymal transition.Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.Hyperoxia induces alveolar epithelial-to-mesenchymal cell transition.Emerging role of mucins in epithelial to mesenchymal transition.MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.Molecular mechanism of cholangiocarcinoma carcinogenesis.Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.
P2860
Q26752391-88323451-3DED-41F2-BA62-F9D959339F8CQ26771988-D4865692-E9F2-4B05-AC26-17F8DBF85ADAQ26799171-010E78E3-0041-480D-96A5-37574C571225Q28397372-983BE378-5358-4252-9320-3CE13CF868FAQ28534349-31EC436B-4021-4E35-A064-FF2C8DDB8172Q33757122-09D2E8A0-7FE6-47D6-A6FF-713769E5E996Q33778346-7D495BF3-FACB-4783-BEC8-E049A36E9F63Q33813109-3DCEBF2D-4CE3-4F38-86B5-F03D81CCFA3FQ34283703-B26F5519-9C7A-4060-95BE-FD64F7555EADQ34565846-87CA90A7-F1C9-49EB-9759-2E0EDB7A4D9BQ34639711-CF779C40-8300-4CFD-B1F1-C9D2097E63E9Q34984377-A04B3EF4-9612-4CCF-9EBB-320F1A788342Q35035238-AC7ED0C6-108B-4FB4-A0CA-51B499BA91A7Q35151213-F782A9CE-E116-4BBE-8F9F-91A72A6C1705Q35153098-50224B47-0C63-4B55-A42C-E78BF8033F20Q35164379-290F2FFA-077E-413B-AC68-340845C35EECQ35364690-BF3C2429-0F5A-4739-AD93-1BA009F1FE1EQ35664592-6F415511-6CB7-48B1-9A03-405567760FF8Q35776476-B31E4EBC-D23C-4159-A9E6-4140D587029DQ35821082-5DEE9D04-D5DE-46CA-BD99-F37632DE8AB5Q35914014-E8CC282F-5343-4BB8-A04F-064FDD237130Q36163116-A97748B3-59E6-489F-9FC3-31FFFF5BD83DQ36326283-C6A42871-A450-4B06-A4C4-AA0FD2241DB0Q36622089-70ADA150-5FDE-4DF9-9A92-DBE1B292C59AQ36683019-8B0CFF9D-EBB0-4218-8CC6-9B7C980A0840Q37077663-98AAB095-4302-4CA5-BFE6-B9ECCDF3C866Q37534719-5A508F37-1331-450E-88D4-2531DB3C92D7Q37576118-FFF2238C-9F78-47CE-AA29-ECDE05CE2EA3Q37584296-FD2BE25F-EEF9-4300-A05A-ED505DED36ACQ37688166-F6B3FE54-7A8D-430C-909B-96BDD6BBFB0FQ38024791-6707ADE7-88C5-406F-88F6-BE2E37CD1826Q38148062-582FE547-B3C7-48CB-94C8-B9EE03F0DE76Q38217475-6470FB9A-6B15-4479-B4EC-1E6A39E268C1Q38662233-049E7CD2-82A2-4102-AA9D-0C63BBB43033Q38812588-19621ABB-6A5C-4A2B-A9DF-2797C3BD9FC9Q38850981-36603039-8749-4D43-BF29-73EC1763C907Q39098768-070CE887-7891-4201-A0B9-7696E0F8F4FEQ39114639-CFDD53A3-24B5-4256-92F9-2DEB138580C0Q39148033-5CDCE2D7-763D-4329-86E3-7AF66F08696DQ39240982-6C02A114-E666-4158-9B24-81BF597E8F44
P2860
E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
E/N-cadherin switch mediates c ...... trahepatic cholangiocarcinoma.
@ast
E/N-cadherin switch mediates c ...... trahepatic cholangiocarcinoma.
@en
type
label
E/N-cadherin switch mediates c ...... trahepatic cholangiocarcinoma.
@ast
E/N-cadherin switch mediates c ...... trahepatic cholangiocarcinoma.
@en
prefLabel
E/N-cadherin switch mediates c ...... trahepatic cholangiocarcinoma.
@ast
E/N-cadherin switch mediates c ...... trahepatic cholangiocarcinoma.
@en
P2093
P2860
P356
P1476
E/N-cadherin switch mediates c ...... trahepatic cholangiocarcinoma.
@en
P2093
S Tsutsumi
T Kobayahi
P2860
P2888
P304
P356
10.1038/BJC.2011.452
P407
P577
2011-11-08T00:00:00Z